M. Elizabeth Halloran

Using social contact data to improve the overall effect estimate of a cluster‐randomized influenza vaccination program in Senegal

Gail E. Potter, J. Sugimoto, N. Carnegie, 2020, Journal of the Royal Statistical Society. Series C, Applied statistics.

Preliminary results of models to predict areas in the Americas with increased likelihood of Zika virus transmission in 2017

A. Vespignani, D. Cummings, S. Merler, 2017, bioRxiv.

Designing a Study of Correlates of Risk for Ebola Vaccination

M. Halloran, I. Longini, P. Gilbert, 2018, bioRxiv.

Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies.

Laura Matrajt, I. Longini, L. Matrajt, 2016, Vaccine.

Improving adolescent human papillomavirus (HPV) immunization uptake in school-based health centers through awareness campaigns.

J. Duchin, L. Page, M. Elizabeth Halloran, 2021, Vaccine.

Histo-Blood Group Antigen Null Phenotypes Associated With a Decreased Risk of Clinical Rotavirus Vaccine Failure Among Children <2 Years of Age Participating in the Vaccine Impact on Diarrhea in Africa (VIDA) Study in Kenya, Mali, and the Gambia

J. Tate, U. Parashar, K. Neuzil, 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials

A. Vespignani, D. Cummings, M. Halloran, 2020, Vaccine.